Adline Chem Lab insider trading and stake changes
BSE: 524604Pharmaceuticals & BiotechnologySmall Cap
Last close ₹15.79₹0.00 (0.00%)
Share price at the BSE close on 12 Oct 2026. Previous close ₹15.79.
52-week range of traded prices to 12 Oct 2026
₹7.60Low, 3 Dec 2025₹16.21High, 13 Oct 2025
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.24 Cr4,835th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −685.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,500
Adline Chem Lab insider trading
All 3 disclosures on record. The company's own latest disclosure on record is from Jun 2024.Insider trading, all companies
Feb 2024
- HEMANT PARIKH₹0.75 Cr14,32,040 sharesReceived · Promoter and Director · 1 Feb 2024 · disclosed 3 Feb · Off Market · stake 1.37% before, 25.85% after
Jan 2024
- Kamlesh J. Laskari HUF₹0.66 Cr12,56,640 sharesGave · Promoter · 31 Jan 2024 · Off Market · held 12,56,640 before, holds none after
Feb 2023
- HEMANT PARIKH14,32,040sharesReceived · Promoter · 1 Feb 2023 · disclosed 3 Feb 2024 · Off Market · stake 1.37% before, 25.85% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Adline Chem Lab stake sales and purchases
All 5 disclosures on record.
Feb 2024
- AcquiredHemant A Parikh · promoter24.48% of the company14,32,040 sharesholds 25.85% after1 Feb 2024 · filed under the 5% rule · Off Market
Jan 2024
- SoldKamlesh Jagdish Laskari HUF & PACs · promoter24.48% of the company14,32,040 shares31 Jan 2024 · filed under the 2% rule · Off Market
- SoldRanak Kamlesh Laskari & PACs · promoter24.48% of the company14,32,040 shares31 Jan 2024 · filed under the 2% rule · Off Market
- SoldRohan Kamlesh Laskari & PACs · promoter24.48% of the company14,32,040 shares31 Jan 2024 · filed under the 2% rule · Off Market
- SoldSohan Kamlesh Laskari & PACs · promoter24.48% of the company14,32,040 shares31 Jan 2024 · filed under the 2% rule · Off Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.